BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36196760)

  • 1. The bacterial virulence factor NleA undergoes host-mediated O-linked glycosylation.
    Burns L; Giannakopoulou N; Zhu L; Xu YZ; Khan RH; Bekal S; Schurr E; Schmeing TM; Gruenheid S
    Mol Microbiol; 2023 Feb; 119(2):161-173. PubMed ID: 36196760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct evidence of host-mediated glycosylation of NleA and its dependence on interaction with the COPII complex.
    Burns L; Le Mauff F; Gruenheid S
    Gut Microbes; 2024; 16(1):2305477. PubMed ID: 38298145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inhibition of COPII trafficking is important for intestinal epithelial tight junction disruption during enteropathogenic Escherichia coli and Citrobacter rodentium infection.
    Thanabalasuriar A; Kim J; Gruenheid S
    Microbes Infect; 2013; 15(10-11):738-44. PubMed ID: 23747681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sec24 interaction is essential for localization and virulence-associated function of the bacterial effector protein NleA.
    Thanabalasuriar A; Bergeron J; Gillingham A; Mimee M; Thomassin JL; Strynadka N; Kim J; Gruenheid S
    Cell Microbiol; 2012 Aug; 14(8):1206-18. PubMed ID: 22432415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and characterization of NleA, a non-LEE-encoded type III translocated virulence factor of enterohaemorrhagic Escherichia coli O157:H7.
    Gruenheid S; Sekirov I; Thomas NA; Deng W; O'Donnell P; Goode D; Li Y; Frey EA; Brown NF; Metalnikov P; Pawson T; Ashman K; Finlay BB
    Mol Microbiol; 2004 Mar; 51(5):1233-49. PubMed ID: 14982621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EspZ of enteropathogenic and enterohemorrhagic Escherichia coli regulates type III secretion system protein translocation.
    Berger CN; Crepin VF; Baruch K; Mousnier A; Rosenshine I; Frankel G
    mBio; 2012; 3(5):. PubMed ID: 23033475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tandem tyrosine phosphosites in the Enteropathogenic Escherichia coli chaperone CesT are required for differential type III effector translocation and virulence.
    Runte CS; Jain U; Getz LJ; Secord S; Kuwae A; Abe A; LeBlanc JJ; Stadnyk AW; Kaper JB; Hansen AM; Thomas NA
    Mol Microbiol; 2018 Jun; 108(5):536-550. PubMed ID: 29509331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enteropathogenic Escherichia coli Uses NleA to Inhibit NLRP3 Inflammasome Activation.
    Yen H; Sugimoto N; Tobe T
    PLoS Pathog; 2015 Sep; 11(9):e1005121. PubMed ID: 26332984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A type III effector antagonizes death receptor signalling during bacterial gut infection.
    Pearson JS; Giogha C; Ong SY; Kennedy CL; Kelly M; Robinson KS; Lung TW; Mansell A; Riedmaier P; Oates CV; Zaid A; Mühlen S; Crepin VF; Marches O; Ang CS; Williamson NA; O'Reilly LA; Bankovacki A; Nachbur U; Infusini G; Webb AI; Silke J; Strasser A; Frankel G; Hartland EL
    Nature; 2013 Sep; 501(7466):247-51. PubMed ID: 24025841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NleB/SseK effectors from
    El Qaidi S; Chen K; Halim A; Siukstaite L; Rueter C; Hurtado-Guerrero R; Clausen H; Hardwidge PR
    J Biol Chem; 2017 Jul; 292(27):11423-11430. PubMed ID: 28522607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The bacterial virulence factor NleA inhibits cellular protein secretion by disrupting mammalian COPII function.
    Kim J; Thanabalasuriar A; Chaworth-Musters T; Fromme JC; Frey EA; Lario PI; Metalnikov P; Rizg K; Thomas NA; Lee SF; Hartland EL; Hardwidge PR; Pawson T; Strynadka NC; Finlay BB; Schekman R; Gruenheid S
    Cell Host Microbe; 2007 Sep; 2(3):160-71. PubMed ID: 18005731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Citrobacter rodentium translocated intimin receptor (Tir) is an essential virulence factor needed for actin condensation, intestinal colonization and colonic hyperplasia in mice.
    Deng W; Vallance BA; Li Y; Puente JL; Finlay BB
    Mol Microbiol; 2003 Apr; 48(1):95-115. PubMed ID: 12657048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The bacterial arginine glycosyltransferase effector NleB preferentially modifies Fas-associated death domain protein (FADD).
    Scott NE; Giogha C; Pollock GL; Kennedy CL; Webb AI; Williamson NA; Pearson JS; Hartland EL
    J Biol Chem; 2017 Oct; 292(42):17337-17350. PubMed ID: 28860194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modelling of infection by enteropathogenic Escherichia coli strains in lineages 2 and 4 ex vivo and in vivo by using Citrobacter rodentium expressing TccP.
    Girard F; Crepin VF; Frankel G
    Infect Immun; 2009 Apr; 77(4):1304-14. PubMed ID: 19188355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virulence gene profiling of enterohemorrhagic (EHEC) and enteropathogenic (EPEC) Escherichia coli strains: a basis for molecular risk assessment of typical and atypical EPEC strains.
    Bugarel M; Martin A; Fach P; Beutin L
    BMC Microbiol; 2011 Jun; 11():142. PubMed ID: 21689465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A C-terminal class I PDZ binding motif of EspI/NleA modulates the virulence of attaching and effacing Escherichia coli and Citrobacter rodentium.
    Lee SF; Kelly M; McAlister A; Luck SN; Garcia EL; Hall RA; Robins-Browne RM; Frankel G; Hartland EL
    Cell Microbiol; 2008 Feb; 10(2):499-513. PubMed ID: 17979986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bringing down the host: enteropathogenic and enterohaemorrhagic Escherichia coli effector-mediated subversion of host innate immune pathways.
    Santos AS; Finlay BB
    Cell Microbiol; 2015 Mar; 17(3):318-32. PubMed ID: 25588886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SepD/SepL-dependent secretion signals of the type III secretion system translocator proteins in enteropathogenic Escherichia coli.
    Deng W; Yu HB; Li Y; Finlay BB
    J Bacteriol; 2015 Apr; 197(7):1263-75. PubMed ID: 25645555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NleB2 from enteropathogenic Escherichia coli is a novel arginine-glucose transferase effector.
    Giogha C; Scott NE; Wong Fok Lung T; Pollock GL; Harper M; Goddard-Borger ED; Pearson JS; Hartland EL
    PLoS Pathog; 2021 Jun; 17(6):e1009658. PubMed ID: 34133469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type Three Secretion System in Attaching and Effacing Pathogens.
    Gaytán MO; Martínez-Santos VI; Soto E; González-Pedrajo B
    Front Cell Infect Microbiol; 2016; 6():129. PubMed ID: 27818950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.